Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business Highlights
08 nov. 2022 16h30 HE
|
Shattuck Labs, Inc.
– Completed enrollment in Phase 1 dose-escalation clinical trial of SL-172154 as monotherapy in platinum-resistant ovarian cancer; complete data expected midyear 2023 – – Dosed first patient in...
Compass Therapeutics to Present at Upcoming Investment Conferences
08 nov. 2022 08h00 HE
|
Compass Therapeutics
BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
07 nov. 2022 08h00 HE
|
Shattuck Labs, Inc.
- Data from two distinct GADLEN product candidates, one targeting CD20 and another targeting B7-H3, enhanced γδT cell killing of tumor cells, demonstrating preclinical proof-of-concept in the...
Shattuck Labs Announces Participation in Upcoming November Conferences
03 nov. 2022 08h30 HE
|
Shattuck Labs, Inc.
AUSTIN, TX and DURHAM, NC, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022
01 nov. 2022 16h30 HE
|
Shattuck Labs, Inc.
AUSTIN, TX and DURHAM, NC, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
Mettler-Toledo International Inc. to Webcast Investor Meeting
28 oct. 2022 16h15 HE
|
Mettler-Toledo, LLC
Columbus, OH, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced it will host an investor meeting in the Boston area on November 7, 2022. A live webcast...
Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12
05 oct. 2022 16h30 HE
|
Shattuck Labs, Inc.
AUSTIN, TX & DURHAM, NC, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...
Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference
08 sept. 2022 09h15 HE
|
Incannex Healthcare
MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...
FRO – Q2 2022 Presentation
25 août 2022 08h03 HE
|
Frontline Ltd.
Please find enclosed the presentation of Frontline Ltd.’s second quarter 2022 results to be held on the webcast / conference call 25 August, 2022 at 15:00 CET. This information is subject to the...
Compass Therapeutics to Present at the 13th Annual Wedbush PacGrow Healthcare Conference
02 août 2022 08h00 HE
|
Compass Therapeutics
BOSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...